In the #RedJournal: Final safety and HRQoL results of the phase II/III Act.In.Sarc study with preoperative NBTXR3 plus radiotherapy versus radiotherapy in locally advanced soft-tissue sarcoma ➡️ sylvie bonvalot bit.ly/Bonvalot2022

New roads in retroperitoneal sarcomas pubmed.ncbi.nlm.nih.gov/36153224/ special issue European Journal of Surgical Oncology #retroperitoneal #sarcomas SPAGN SARCOMA Polskie Towarzystwo Chirurgii Onkologicznej Narodowy Instytut Onkologii, Warszawa Polskie Towarzystwo Onkologiczne thank you sylvie bonvalot

Excellent review of this extremely rare sarcomas, formerly grouped into the Ewing’s sarcoma family.

🎉 Congrats to Jan van Rees’ on winning the best clinical research 👏🏻Anticancer Fund Andreas Brandl @Simple_Trials André Mihaljevic Wim Ceelen Laura Lorenzon sylvie bonvalot #chemotherapy #surgicaloncology #rectalcancer #youngsurgeons #juniorsurgeons EYSAC #ESSO41

Interesting article "Percutaneous Uterine Needle Biopsy with Microscopic and Array-CGH Analyses for Preoperative Sarcoma Diagnosis in Patients with Suspicious Myometrial Tumors on MRI: A Prospective Pilot Study (SARCGYN)" (via #pubmedontap) ncbi.nlm.nih.gov/pubmed/36287348

Whoops surgery of uterine sarcoma shouldn’t exist anymore!

Percutaneous biopsy of myometrial tumors identified on MRI is safe and effective sylvie bonvalot CTOS #CTOS2022 #CTOSTweeTOS OncoAlert #sarcoma Nat'l LMS Foundation

The 8 pillars of TARPSWG reunited in #Vancouver #CTOS2022 #CTOSTweeTOS From a small meeting in #Milan to the largest #retroperitoneal #sarcoma group of the world. What #leaders look like❗️

#5thMasterclass Debating: to treat or not to treat sts with neoadjuvant chemo.. sylvie bonvalot Sarah Watson

Learning a lot with Silvia Stacchiotti and sylvie bonvalot Hellenic Group of Sarcomas and rare tumors #sarcoma #gist meeting

Fantastic! Such an important achievement for ASPS patients and the #sarcoma community. A new era for immunotherapy in sarcoma is starting…. Silvia Stacchiotti Anna Maria Frezza Roberta Sanfilippo

"Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial" (via #pubmedontap) ncbi.nlm.nih.gov/pubmed/37777684

LMS-04: ▫️DOX v DOX & trabectedin with ongoing TRAB ▫️Randomised ph3, n=150 #LMS ▫️Updated results at #ESMO23 ⭐️Improved PFS1, PFS2, OS ⭐️ ▪️RR before surg 13% v 36% 🔹more surgery in DOX+TRAB ▪️PFS 6.21 v 12.19m ▪️2 yr PFS 2.7 v 30.2% 🔸OS 23.78 v 33.08m 🔸2yr OS 49 v 69%

Excellent discussions on going in #sarcoma session on #hereditary and #genomicpredisposing syndromes at #ESMO23. Important considerations & emerging evidence of how these patients need #identified & #treated #differently. Professor DM Thomas sylvie bonvalot WinetteVanDerGraaf Tom Wei-Wu Chen

Surgical, med onc and rad onc perspectives on hereditary syndromes in #sarcoma by sylvie bonvalot WinetteVanDerGraaf Beate Timmerman Really excellent session, panel and discussions at #ESMO23🙏👏

🔶 Beyond study results, @Institut_Curie's physicians also share their expertise through Special Sessions at #ESMO23, as: ➡️ Prof. Anne Vincent-Salomon, discussing #ArtificialIntelligence in cancer prognosis ➡️ Prof. sylvie bonvalot, about treatment of sarcoma pts w/genetic predisposition

TARPSWG 10th yr anniversary. Who could have guessed back then how much we would have been able to achieve? Hundreds of members for multiple countries and 5 continents! And an observational study with thousands of pts in it! CTOS Society of Surgical Oncology European Society of Surgical Oncology (ESSO) EORTC

Very interesting - and persuasive- presentation by sylvie bonvalot Interestingly, numbers to define “high-volume” centers are tipically lower than would be anticipated #CTOS2023 CTOS

"Diagnostic accuracy and safety of percutaneous core needle biopsy of retroperitoneal tumours" (via #pubmedontap) ncbi.nlm.nih.gov/pubmed/38086314